PTPRC and neoplasm: Indeed, s.c.-delivered N-803 enhanced PD-L1 expression on CD45+ hematopoietic cells in the primary tumor, lung parenchyma and vasculature, and spleen of 4T1 TN breast tumor-bearing mice (Fig. 1a).